Clincosm LogoSign in Get a demo

recurrent epithelial ovarian cancer

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • (no location specified)
Jan 17, 2023

Recurrent Ovarian Cancer, Recurrent Epithelial Cancer of Ovary, Recurrent Epithelial Ovarian Cancer Trial in Durham, Oklahoma

Recruiting
  • Recurrent Ovarian Cancer
  • +6 more
  • Durham, North Carolina
  • +2 more
Jul 26, 2022

Recurrent Epithelial Ovarian Cancer Trial in Seoul (Standard salvage therapy, Standard salvage therapy + SABR)

Recruiting
  • Recurrent Epithelial Ovarian Cancer
  • Standard salvage therapy
  • Standard salvage therapy + SABR
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jun 29, 2022

Recurrent Epithelial Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Peritoneal Cancer Trial in Canada, United States

Active, not recruiting
  • Recurrent Epithelial Ovarian Cancer
  • +2 more
  • DPX-Survivac
  • +2 more
  • Palo Alto, California
  • +8 more
Jun 16, 2021

Recurrent Epithelial Ovarian Cancer Trial in Berlin (Catumaxomab)

Completed
  • Recurrent Epithelial Ovarian Cancer
  • Berlin, Germany
    Charité Campus Virchow-Klinikum
Feb 17, 2015